Strengthening collaboration with UNODC
20 February 2017 – The World Health Organization and the United Nations Office on Drugs and Crime (UNODC) last week made official plans for strengthened collaboration on the public health issues relating to drug use around the world. The Memorandum of Understanding signed builds on the ongoing collaboration between the two UN entities, already intensive in the areas of drug dependence treatment and care. Areas for further joint work will include prevention of drug use and drug use disorders, improving access to medicines under international control, addressing the challenges of new psychoactive substances (NPS) and monitoring drug use and its health and social consequences. The planned collaborative activities will facilitate implementation of operational recommendations on health-related issues agreed at the UN General Assembly’s special session on the world drug problem held in April 2016.
The 140th session of the WHO Executive Board (EB), scheduled for January 2017, will include further discussion on the topic “Public health dimension of the world drug problem,” as decided at the sixty-ninth World Health Assembly (WHA) in May 2016.
In preparation for the EB, the WHO Secretariat has published an update on the Secretariat’s activities on the public health dimensions of the world drug problem, including collaboration with United Nations Office on Drugs and Crime (UNODC) and International Narcotics Control Board (INCB).
Cannabis is globally the most commonly used psychoactive substance under international control. In 2013, an estimated 181.8 million people aged 15-64 years used cannabis for nonmedical purposes.
This publication builds on contributions from a broad range of experts and researchers from different parts of the world. It aims to present the current knowledge on the impact of nonmedical cannabis use on health.
This policy brief provides up-to-date information on drug use and road safety to support informed decisions on road safety and drug policies in WHO Member States.
The document describes the impact of drug use on road safety; suggests what can be done to reduce drug-related crashes, injuries and deaths on the roads; and identifies priorities and possibilities for further action.
1.7 bedsper 100 000 population are available for the treatment of alcohol and drug use disordersBeds for the treatment of alcohol and drug use disorders
The Global Information System on Alcohol and Health
The Global Information System on Alcohol and Health (GISAH) provides easy and rapid access to a wide range of alcohol-related health indicators. It is an essential tool for assessing and monitoring the health situation and trends related to alcohol consumption, alcohol-related harm, and policy responses in countries.
This web site contains information pertaining to psychoactive substance use and abuse, and also information about the World Health Organization's projects and activities in the areas of substance use and substance dependence.
WHO is the only agency dealing with all psychoactive substances, regardless of their legal status. WHO’s mandate in the area of psychoactive substance use includes:
- Prevention and reduction of the negative health and social consequences of psychoactive substance use;
- Reduction of the demand for non-medical use of psychoactive substances;
- Assessment of psychoactive substances so as to advise the United Nations with regard to their regulatory control.
Since its founding in 1948, WHO has played a leading role in supporting countries to prevent and reduce the problems due to psychoactive substance use, and in recommending which psychoactive substances should be regulated. In 2000, the Department of Substance Abuse was merged with the Department of Mental Health to form the Department of Mental Health and Substance Abuse, reflecting the many common approaches of management of mental health and substance use disorders.